|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02235 MICROTECH MED-B
Nominal 
5.900 0.000 (0.000%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 345,615 | 36.484% | 253,228 | 173,607 | 151,404 | 75,277 |
| Cost of Sales | -- | -- | -- | -- | (80,521) | (38,733) |
| Gross Profit | -- | -- | -- | -- | 70,883 | 36,544 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (5,120) | 13.071% | (4,528) | (4,944) | (1,229) | (188) | |
| Profit / (Loss) on Disposal | -- | -- | -- | (8) | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (63,149) | -49.421% | (124,852) | (35,042) | (48,153) | (121,250) | |
| Taxation | 31 | -- | (164) | (2) | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 241 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (63,118) | -49.512% | (125,016) | (35,043) | (48,153) | (121,009) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (62,168) | -17.151% | (75,037) | (85,401) | (23,299) | (2,068) |
| Depreciation & Amortisation | -- | -- | 11,173 | 10,484 | 8,332 | 5,484 |
| Directors' Emoluments | -- | -- | 4,582 | 4,546 | 16,254 | 68,083 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -15.000 | -48.276% | -29.000 | -8.000 | -13.000 | -39.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.359) | (0.280) | (0.118) | (0.031) |
| NBV per share ($) | 7.839 | -- | 4.841 | 5.196 | 5.277 | -- |
| Remarks: | Real time quote last updated: 17/04/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -63,118,239 |
| %Change | -49.512% |
| EPS / (LPS) | RMB -0.150 |
| NBV Per Share (¥) | RMB 7.839 |